Usana Health Sciences Inc.’s stock
USNA,
fell 2% before turning flat in after-hours trade Tuesday, after the maker of nutritional supplements missed earnings estimates for the third quarter. Salt Lake City, Utah-based Usana posted net income of $11.3 million, or 59 cents a share, for the quarter, down from $14.9 million, or 78 cents a share, in the year-earlier period. Sales fell to $213.4 million from $233.3 million. The FactSet consensus was for EPS of 64 cents and revenue of $220.0 million. “Operating results for the third quarter did not meet our expectations, largely because of challenging economic conditions across many of our regions and a lower cadence of promotional activity during the quarter,” CEO John Brown said in a statement. “These factors made it difficult to generate both Active Customer growth and top line momentum in our business.” The company lowered its full-year guidance and now expects EPS to range from $2.80 to $3.05, compared with prior guidance of $2.65 to $3.30. It expects sales of $900 million to $920 million, compared with prior guidance of $900 million to $950 million. The stock has gained 4% in the year to date, while the S&P 500
SPX,
has gained 10.6%.
Read the full article here
